1. Home
  2. LRMR vs ABAT Comparison

LRMR vs ABAT Comparison

Compare LRMR & ABAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

N/A

Current Price

$3.03

Market Cap

253.5M

Sector

Health Care

ML Signal

N/A

Logo American Battery Technology Company

ABAT

American Battery Technology Company

N/A

Current Price

$1.11

Market Cap

302.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
LRMR
ABAT
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Mining
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
253.5M
302.3M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
LRMR
ABAT
Price
$3.03
$1.11
Analyst Decision
Strong Buy
Buy
Analyst Count
11
2
Target Price
★ $14.40
$6.00
AVG Volume (30 Days)
1.3M
★ 2.3M
Earning Date
11-24-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$45.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.92
$1.14
52 Week High
$6.42
$5.33

Technical Indicators

Market Signals
Indicator
LRMR
ABAT
Relative Strength Index (RSI) 59.82 31.50
Support Level $2.89 N/A
Resistance Level $4.19 $1.64
Average True Range (ATR) 0.25 0.13
MACD 0.09 0.01
Stochastic Oscillator 95.93 5.32

Price Performance

Historical Comparison
LRMR
ABAT

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Its flagship product candidate, nomlabofusp, is a subcutaneously administered recombinant fusion protein designed to deliver frataxin (FXN) to the mitochondria of patients with Friedreich's ataxia (FA), a rare genetic disease characterized by insufficient production of FXN. The company also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.

About ABAT American Battery Technology Company

American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. The company also advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company focuses on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.

Share on Social Networks: